Staphylococcus aureus as a risk factor for bloodstream infection in children with postoperative mediastinitis

Samir S Shah1, Ebbing Lautenbach, Caroline B Long

  • 1Center for Education and Research on Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Insights

Bloodstream infection (BSI) is a common complication of postoperative mediastinitis. Staphylococcus aureus significantly increases the risk of developing BSI in these patients.

Area of Science:

  • Infectious Diseases
  • Surgical Infections
  • Critical Care Medicine

Background:

  • Postoperative mediastinitis frequently leads to bloodstream infections (BSI), affecting over half of cases.
  • Identifying specific pathogens that increase BSI risk is crucial for patient management.

Purpose of the Study:

  • To investigate the association between Staphylococcus aureus and the development of BSI in patients with postoperative mediastinitis.
  • To determine if S. aureus is an independent risk factor for BSI in this population.

Main Methods:

  • Retrospective cohort study design.
  • Data collected from 1995 to 2003.
  • Statistical analysis including adjusted odds ratios and confidence intervals.

Main Results:

  • Postoperative mediastinitis caused by Staphylococcus aureus was identified as an independent risk factor for BSI.
  • The adjusted odds ratio for BSI in the context of S. aureus mediastinitis was 6.4 (95% CI, 1.4-29.3).
  • Mediastinitis due to S. aureus presents a higher intrinsic risk for BSI compared to other pathogens.

Conclusions:

  • Staphylococcus aureus is a significant risk factor for bloodstream infections in patients with postoperative mediastinitis.
  • Clinical vigilance for BSI is warranted in patients with S. aureus-related mediastinitis.
  • These findings highlight the importance of pathogen-specific risk assessment in surgical site infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...